Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 18;104(29):e43370.
doi: 10.1097/MD.0000000000043370.

Pediatric thrombosis: Risk factors, diagnosis, and prevention strategies

Affiliations
Review

Pediatric thrombosis: Risk factors, diagnosis, and prevention strategies

Emmanuel Ifeanyi Obeagu. Medicine (Baltimore). .

Abstract

Pediatric thrombosis is an underdiagnosed condition with potentially life-threatening consequences. Unlike adult thrombosis, the pediatric variant is characterized by age-specific risk factors, such as central venous catheters, infections, and genetic predispositions, which demand a tailored approach to diagnosis and management. Neonates and adolescents are particularly vulnerable due to physiological and hormonal changes, respectively, that amplify their susceptibility to thrombotic events. A deeper understanding of these factors is crucial for early detection and effective prevention strategies. The diagnostic process for pediatric thrombosis is fraught with challenges owing to the nonspecific nature of symptoms and variability in presentation across age groups. Imaging modalities, such as Doppler ultrasound and computed tomography pulmonary angiography, remain the cornerstone for identifying thrombotic events. However, laboratory investigations, including thrombophilia testing and d-dimer assays, are essential adjuncts, particularly in cases of idiopathic or recurrent thrombosis. Timely and accurate diagnosis is pivotal for reducing morbidity and mortality associated with this condition.

Keywords: anticoagulation; diagnosis; pediatric thrombosis; prevention; risk factors.

PubMed Disclaimer

Conflict of interest statement

The author has no funding and conflicts of interest to disclose.

Similar articles

References

    1. Monagle P, Cuello CA, Augustine C, et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018;2:3292–316. - PMC - PubMed
    1. Manlhiot C, Menjak IB, Brandao LR, et al. Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery. Circulation. 2011;124:1511– 9. - PubMed
    1. Giglia TM, Massicotte MP, Tweddell JS, et al. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2013;128:2622–703. - PubMed
    1. Achey MA, Nag UP, Robinson VL, et al. The developing balance of thrombosis and hemorrhage in pediatric surgery: clinical implications of age-related changes in hemostasis. Clin Appl Thromb Hemost. 2020;26:1076029620929092. - PMC - PubMed
    1. Spentzouris G, Scriven RJ, Lee TK, Labropoulos N. Pediatric venous thromboembolism in relation to adults. J Vasc Surg. 2012;55:1785–93. - PubMed

Substances